Below are the most recent publications written about "Tuberculosis, Pulmonary" by people in Profiles.
-
Chang X, Li Z, Thai PVK, Ha DTM, Thuong NTT, Wee D, Subhan ASBM, Silcocks M, Chee CBE, Nhu NTQ, Heng CK, Teo YY, Singhal A, Oehlers SH, Yuan JM, Koh WP, Caws M, Khor CC, Dorajoo R, Dunstan SJ. Genome-wide association study reveals a novel tuberculosis susceptibility locus in multiple East Asian and European populations. Genome Med. 2026 May 27; 18(1).
-
Gupte AN, Boisson-Walsh A, Huaman MA, Bhavaraju R, Gao Y, Hom D, Ellner J, Kornfeld H. Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review. Clin Infect Dis. 2026 Apr 13; 82(Supplement_2):S60-S67.
-
Pavan Kumar N, Nancy P A, Hissar S, Sivakumar S, Viswanathan V, Bethunaickan R, Kornfeld H, Babu S. Complement profiling for treatment outcomes in pulmonary TB. Front Immunol. 2026; 17:1679947.
-
Kempker RR, Salindri AD, Avaliani T, Kornfeld H, Auld SC, Jakobia N, Day CL, Subuddhi A, Krish KN, Vashakidze S, Avaliani Z, Goginashvili L, Bryan C, Bernheim A, Kipiani M, Magee MJ. High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis. Thorax. 2026 01 15; 81(2):170-178.
-
Choi H, Lee K, Han K, Shin DW, Lee H. Nontuberculous mycobacterial pulmonary disease risk in tuberculosis survivors: A nationwide Korean cohort study. Int J Infect Dis. 2026 Mar; 164:108387.
-
Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Shivakumar SVBY, Salgame P, Bollinger RC, Sarkar S, Gupte AN. Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort Analysis. Chest. 2026 Jan; 169(1):64-72.
-
Nancy Pandiarajan A, Kumar NP, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S, Bethunaickan R, Viswanathan V, Kornfeld H, Babu S. Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes. Pathogens. 2025 Feb 04; 14(2).
-
Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh CR, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India. Clin Infect Dis. 2024 10 15; 79(4):1034-1038.
-
Rajamanickam A, Kothandaraman SP, Kumar NP, Viswanathan V, Shanmugam S, Hissar S, Nott S, Kornfeld H, Babu S. Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Front Immunol. 2024; 15:1447161.
-
Lai R, Williams T, Rakib T, Lee J, Behar SM. Heterogeneity in lung macrophage control of Mycobacterium tuberculosis is modulated by T cells. Nat Commun. 2024 Jul 08; 15(1):5710.